Home > Financial Ratios > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 16.0115.7212.709.197.74

What is the latest Core EBITDA Margin ratio of KILITCH DRUGS (INDIA) ?

The latest Core EBITDA Margin ratio of KILITCH DRUGS (INDIA) is 16.01 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar202516.01
Mar202415.72
Mar202312.70
Mar20229.19
Mar20217.74

How is Core EBITDA Margin of KILITCH DRUGS (INDIA) Trending?

Years Core EBITDA Margin % Change
Mar2025 16.01
1.84
Mar2024 15.72
23.78
Mar2023 12.7
38.19
Mar2022 9.19
18.73
Mar2021 7.74 -

Other Financial Ratios of KILITCH DRUGS (INDIA)


Compare Core EBITDA Margin ratio of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹603.1 Cr 2.2% -2.2% 10.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,494.0 Cr -0.5% -1.9% -3% Stock Analytics
DIVIS LABORATORIES ₹170,514.0 Cr 1.8% 1.3% 10.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,044.0 Cr 2% 2.4% 11.2% Stock Analytics
CIPLA ₹121,574.0 Cr -0.2% -0.7% 1.9% Stock Analytics
DR REDDYS LABORATORIES ₹105,919.0 Cr -1% 2.5% -4.4% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

2.2%

-2.2%

10.5%

SENSEX

1%

0.6%

7.8%


You may also like the below Video Courses